2.29 Time from Diagnosis to Treatment in AML and Real-World Data with Dr. Sherrie Aspinall

OncologyMedicineHealth Policy
Written By Kerrington .

This week we wonder incredulously how this abstract from ASH titled "Time from diagnosis to treatment does not affect outcome in intensively treated patients with newly diagnosed acute myeloid leukemia" was selected as one of the top abstracts from the conference. In the second half of the episode we interview Dr. Sherrie Aspinall of the Veterans Administration on how to use real-world data. Her new paper is titled "Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration".

Kerrington .
Previous

2.30 Questions from a Medical Student & Epidemiology with Dr. Ellie Murray
Next

2.28 Trastuzumab in Later Lines of Therapy for HER2+ Breast Cancer, Kaplan-Meier Curves, & Patreon